Shigeto Ueda - Search Results

Year	Number of Results
2004	1
2006	3
2007	2
2008	3
2009	3
2010	4
2011	4
2012	4
2013	2
2014	3
2015	3
2016	4
2017	3
2018	3
2019	1
2024	0

1

Intracellular hypoxia measured by ¹⁸F-fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen receptor-positive breast cancer.

Asano A, Ueda S, Kuji I, Yamane T, Takeuchi H, Hirokawa E, Sugitani I, Shimada H, Hasebe T, Osaki A, Saeki T. Asano A, et al. Among authors: ueda s. Breast Cancer Res. 2018 Jul 27;20(1):78. doi: 10.1186/s13058-018-0970-6. Breast Cancer Res. 2018. PMID: 30053906 Free PMC article.

2

Invasive carcinoma with neuroendocrine differentiation of the breast showing triple negative, large and basal cell-like features.

Kawasaki T, Hasebe T, Oiwa M, Sugiyama K, Muramatsu C, Ueda S, Osaki A, Ichikawa J, Teramoto N, Hoshida Y. Kawasaki T, et al. Among authors: ueda s. Pathol Int. 2019 Aug;69(8):502-504. doi: 10.1111/pin.12832. Epub 2019 Jul 23. Pathol Int. 2019. PMID: 31338942 No abstract available.

3

18F-Fluoroestradiol PET/CT Correctly Diagnosed 18F-FDG-Avid Inflammatory Lymph Nodes in a Patient With Estrogen Receptor-Positive Breast Cancer.

Yamane T, Ueda S, Seto A, Kuji I. Yamane T, et al. Among authors: ueda s. Clin Nucl Med. 2018 May;43(5):379-380. doi: 10.1097/RLU.0000000000002041. Clin Nucl Med. 2018. PMID: 29485433

4

In vivo imaging of eribulin-induced reoxygenation in advanced breast cancer patients: a comparison to bevacizumab.

Ueda S, Saeki T, Takeuchi H, Shigekawa T, Yamane T, Kuji I, Osaki A. Ueda S, et al. Br J Cancer. 2016 May 24;114(11):1212-8. doi: 10.1038/bjc.2016.122. Epub 2016 May 3. Br J Cancer. 2016. PMID: 27140309 Free PMC article. Clinical Trial.

5

Patritumab plus trastuzumab and paclitaxel in human epidermal growth factor receptor 2-overexpressing metastatic breast cancer.

Mukai H, Saeki T, Aogi K, Naito Y, Matsubara N, Shigekawa T, Ueda S, Takashima S, Hara F, Yamashita T, Ohwada S, Sasaki Y. Mukai H, et al. Among authors: ueda s. Cancer Sci. 2016 Oct;107(10):1465-1470. doi: 10.1111/cas.13017. Epub 2016 Sep 15. Cancer Sci. 2016. PMID: 27452985 Free PMC article. Clinical Trial.

6

18F-fluorodeoxyglucose positron emission tomography optimizes neoadjuvant chemotherapy for primary breast cancer to achieve pathological complete response.

Ueda S, Saeki T, Shigekawa T, Omata J, Moriya T, Yamamoto J, Osaki A, Fujiuchi N, Misumi M, Takeuchi H, Sakurai T, Tsuda H, Tamura K, Ishida J, Abe Y, Imabayashi E, Kuji I, Matsuda H. Ueda S, et al. Int J Clin Oncol. 2012 Jun;17(3):276-82. doi: 10.1007/s10147-011-0287-2. Epub 2011 Aug 10. Int J Clin Oncol. 2012. PMID: 21830087

7

Membranous and cytoplasmic expression of epidermal growth factor receptor in metastatic pancreatic ductal adenocarcinoma.

Einama T, Ueda S, Tsuda H, Ogasawara K, Hatsuse K, Matsubara O, Todo S, Yamamoto J. Einama T, et al. Among authors: ueda s. Exp Ther Med. 2012 Jun;3(6):931-936. doi: 10.3892/etm.2012.518. Epub 2012 Mar 15. Exp Ther Med. 2012. PMID: 22969995 Free PMC article.

8

Fibrotic focus: An important parameter for accurate prediction of a high level of tumor-associated macrophage infiltration in invasive ductal carcinoma of the breast.

Shimada H, Hasebe T, Sugiyama M, Shibasaki S, Sugitani I, Ueda S, Gotoh Y, Yasuda M, Arai E, Osaki A, Saeki T. Shimada H, et al. Among authors: ueda s. Pathol Int. 2017 Jul;67(7):331-341. doi: 10.1111/pin.12550. Epub 2017 Jun 7. Pathol Int. 2017. PMID: 28590017 Free article.

9

Correction to: Intracellular hypoxia measured by F-18 fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen-receptor positive breast (BRCR-D17-00693).

Asano A, Ueda S, Kuji I, Yamane T, Takeuchi H, Hirokawa E, Sugitani I, Shimada H, Hasebe T, Osaki A, Saeki T. Asano A, et al. Among authors: ueda s. Breast Cancer Res. 2018 Sep 5;20(1):107. doi: 10.1186/s13058-018-1038-3. Breast Cancer Res. 2018. PMID: 30185224 Free PMC article.

10

Baseline tumor oxygen saturation correlates with a pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy.

Ueda S, Roblyer D, Cerussi A, Durkin A, Leproux A, Santoro Y, Xu S, O'Sullivan TD, Hsiang D, Mehta R, Butler J, Tromberg BJ. Ueda S, et al. Cancer Res. 2012 Sep 1;72(17):4318-28. doi: 10.1158/0008-5472.CAN-12-0056. Epub 2012 Jul 9. Cancer Res. 2012. PMID: 22777823 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

39 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year